Blackcurrant formula
1 paper4 findings
- 1 lab in 1 country
- Funders: Ministry of Business, Innovation and Employment and 1 more
- Human trial1
Outcomes
4Circulating neurotransmitter metabolites
downin humans1
1 study
Circulating neurotransmitter metabolites
downin humans1
Blackcurrant formula decreases circulating neurotransmitter metabolites in humans.
“These changes corresponded with significant reductions (q < 0.05) in circulating neurotransmitter metabolites xanthurenic acid, 3-methoxy-4-hydroxyphenylglycol and vanillylmandelic acid.”
Human trialHealthy older adultsBeverageBloodSingle doseAcuten = 26
Frontiers in pharmacology30 Sep 2026
Biomarkers of monoamine oxidase activity
downin humans1
1 study
Biomarkers of monoamine oxidase activity
downin humans1
Blackcurrant formula decreases biomarkers of monoamine oxidase activity in humans.
“Reduction in biomarkers of MAO activity were measured following acute supplementation with BCF, but not placebo, with significant treatment × time interactions (q < 0.01)”
Human trialHealthy older adults; compared with placeboBeverageBloodSingle doseAcuten = 26
Frontiers in pharmacology30 Sep 2026
Mental fatigue
downin humans1
1 study
Mental fatigue
downin humans1
Blackcurrant formula decreases mental fatigue in humans.
“a strong trend in reduced mental fatigue (p = 0.046, q = 0.067) were measured following 4 weeks of BCF supplementation.”
Human trialHealthy older adults; reported as a trendBeverageDaily4 weeksn = 26
Frontiers in pharmacology30 Sep 2026
Rapid Visual Information Processing false alarms
downin humans1
1 study
Rapid Visual Information Processing false alarms
downin humans1
Blackcurrant formula decreases rapid Visual Information Processing false alarms in humans.
“A significant reduction in Rapid Visual Information Processing (RVIP) false alarms (p = 0.022)”
Human trialHealthy older adultsBeverageDaily4 weeksn = 26
Frontiers in pharmacology30 Sep 2026